Drugs / Native Escherichia coli asparaginase
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT02013167 Comparator | Jan 2014 → Dec 2015 | B-cell acute lymphoblastic leukemia | Amgen | Terminated | Met primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Native Escherichia coli asparaginase | “native Escherichia coli asparaginase, polyethylene glycol linked to asparaginase (PEG-asparaginase)” NCT02013167 ↗ |